데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
85-87-0Cc1ncc(CO)c(CN)c1ONHZMQXZHNVQTQA-UHFFFAOYSA-NPyridoxamine is a monohydroxypyridine that is pyridine substituted by a hydroxy group at position 3, an aminomethyl group at position 4, a hydroxymethyl group at position 5 and a methyl group at position 2. The 4-aminomethyl form of vitamin B6, it is used (in the form of the hydrochloride salt) for treatment of diabetic nephropathy. It has a role as an iron chelator, a mouse metabolite, a Saccharomyces cerevisiae metabolite, a nephroprotective agent, a plant metabolite, an Escherichia coli metabolite and a human metabolite. It is a vitamin B6, a monohydroxypyridine, a hydroxymethylpyridine and an aminoalkylpyridine. It is a conjugate base of a pyridoxaminium(1+).
Positive
2.96
2.7
Agilent XCT
Electrospray ionization
formic acid (5.3nM)
140.12 Ų [M-H]- [CCS Type: DT; Method: stepped-field]
133.9 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
134 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated with Agilent tune mix (Agilent)]
130 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine]
136.4 Ų [M-H]-
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
85-87-0DTXSID6046929CHEMBL593019CHEBI:16410